Cargando…

Factors associated with serum fetuin-A concentrations after long-term use of different phosphate binders in hemodialysis patients

BACKGROUND: Fetuin-A is known as a circulating inhibitor of vascular calcification. Factors associated with serum fetuin-A concentrations after long-term use of different phosphate binders in hemodialysis patients is still uncertain. METHODS: In the post-hoc study, we analyzed serum fetuin-A and bio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Hsin-Hung, Liou, Hung-Hsiang, Wu, Ming-Shiou, Huang, Chiu-Ching
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4804565/ https://www.ncbi.nlm.nih.gov/pubmed/27007989 http://dx.doi.org/10.1186/s12882-016-0245-3

Ejemplares similares

Analysis of serum phosphate control and phosphate binder utilization in incident hemodialysis patients
por: Farrand, Kimberly F, et al.
Publicado: (2014)

Higher Intra-Dialysis Serum Phosphorus Reduction Ratio as a Predictor of Mortality in Patients on Long-Term Hemodialysis
por: Fang, Yu-Wei, et al.
Publicado: (2019)

Serum Fetuin A and Chemerin Levels Correlate with Hepatic Steatosis and Regional Adiposity in Maintenance Hemodialysis Patients
por: Chen, Hung-Yuan, et al.
Publicado: (2012)

Effectiveness and cost-efficiency of phosphate binders in hemodialysis
por: Fröschl, Barbara, et al.
Publicado: (2009)

Inverted U-Curve Association between Serum Indoxyl Sulfate Levels and Cardiovascular Events in Patients on Chronic Hemodialysis
por: Tsai, Ming-Hsien, et al.
Publicado: (2021)

Effect of Tenapanor on Phosphate Binder Pill Burden in Hemodialysis Patients
por: Akizawa, Tadao, et al.
Publicado: (2021)

Intact FGF23 predicts serum phosphate improvement after combined nicotinamide and phosphate binder treatment in hemodialysis patients
por: Egli-Spichtig, Daniela, et al.
Publicado: (2023)

Relation of Serum and Vitreous Concentrations of Fetuin-A with Diabetic Retinopathy
por: Zhao, Chunming, et al.
Publicado: (2015)

Association of Serum Aluminum Levels with Mortality in Patients on Chronic Hemodialysis
por: Tsai, Ming-Hsien, et al.
Publicado: (2018)

Effects of education on low-phosphate diet and phosphate binder intake to control serum phosphate among maintenance hemodialysis patients: A randomized controlled trial
por: Lim, Eunsoo, et al.
Publicado: (2018)

Phosphate binder pill burden, adherence, and serum phosphorus control among hemodialysis patients converting to sucroferric oxyhydroxide
por: Gray, Kathryn, et al.
Publicado: (2019)

Associations of Calcium from Food Sources versus Phosphate Binders with Serum Calcium and FGF23 in Hemodialysis Patients
por: Mahdavi, Sara, et al.
Publicado: (2019)

Gut Microbiome-Derived Uremic Toxin Levels in Hemodialysis Patients on Different Phosphate Binder Therapies
por: Wang, Lin-Chun, et al.
Publicado: (2021)

A New Predictive Equation for Estimating Serum Ionized Calcium Levels in Patients on Chronic Hemodialysis
por: Hung, Wei-Li, et al.
Publicado: (2023)

European hemodialysis patient satisfaction with phosphate binders is associated with serum phosphorus levels: the Dialysis Outcomes and Practice Patterns Study
por: McCullough, Keith, et al.
Publicado: (2021)

Fetuin-A, inflammation, and coronary artery calcification in hemodialysis patients
por: Turkmen, K., et al.
Publicado: (2011)

Potentially modifiable factors associated with non-adherence to phosphate binder use in patients on hemodialysis
por: Martins, Maria Tereza Silveira, et al.
Publicado: (2013)

Calcium-based phosphate binder use is associated with lower risk of osteoporosis in hemodialysis patients
por: Hashimoto, Hiroko, et al.
Publicado: (2021)

Long-term effects of the iron-based phosphate binder, sucroferric oxyhydroxide, in dialysis patients
por: Floege, Jürgen, et al.
Publicado: (2015)

Nutritional Predictors of Mortality in Long Term Hemodialysis Patients
por: Weng, Cheng-Hao, et al.
Publicado: (2016)

One-Year Historical Cohort Study of the Phosphate Binder Sucroferric Oxyhydroxide in Patients on Maintenance Hemodialysis
por: Kendrick, Jessica, et al.
Publicado: (2019)

Serum phosphate as an additional marker for initiating hemodialysis in patients with advanced chronic kidney disease
por: Lu, Yueh-An, et al.
Publicado: (2015)

Influence of pH and phosphate concentration on the phosphate binding capacity of five contemporary binders. An in vitro study
por: Schumacher, Stefan P, et al.
Publicado: (2018)

Iron-based phosphate binders: do they offer advantages over currently available phosphate binders?
por: Negri, Armando Luis, et al.
Publicado: (2015)

Phosphate binders affect vitamin K concentration by undesired binding, an in vitro study
por: Neradova, A., et al.
Publicado: (2017)

Long-term safety and efficacy of ferric citrate in phosphate-lowering and iron-repletion effects among patients with on hemodialysis: A multicenter, open-label, Phase IV trial
por: Lee, Chien-Te, et al.
Publicado: (2022)

Long-Term Comparison between Waste Paper Fly Ash and Traditional Binder as Hydraulic Road Binder Exposed to Sulfate Concentrations
por: Baloochi, Hani, et al.
Publicado: (2022)

Comparative Gut Microbiome Differences between Ferric Citrate and Calcium Carbonate Phosphate Binders in Patients with End-Stage Kidney Disease
por: Wu, Ping-Hsun, et al.
Publicado: (2020)

Serum Intact Fibroblast Growth Factor 23 Levels Are Negatively Associated with Bone Mineral Density in Chronic Hemodialysis Patients
por: Lee, Wen-Teng, et al.
Publicado: (2023)

Sevelamer as a phosphate binder in adult hemodialysis patients: an evidence-based review of its therapeutic value
por: Nadin, Carole
Publicado: (2005)

The association of long-term blood pressure variability with hemodialysis access thrombosis
por: Hsieh, Mu-Yang, et al.
Publicado: (2022)

Fetuin, an inhibitor of lymphocyte transformation. The interaction of fetuin with phytomitogens and a possible role for fetuin in fetal development
Publicado: (1975)

Lower serum potassium combined with lower sodium concentrations predict long-term mortality risk in hemodialysis patients
por: Hwang, Jyh-Chang, et al.
Publicado: (2013)

Urine and serum fetuin-A levels in patients with urolithiasis
por: Arora, Rajat, et al.
Publicado: (2017)

Association between peripheral arterial occlusive disease and cardiothoracic ratio in patients on chronic hemodialysis
por: Liou, Kang-Yi, et al.
Publicado: (2016)

Pharmacology of the Phosphate Binder, Lanthanum Carbonate
por: Damment, Stephen JP
Publicado: (2011)

Relationship between Fetuin A, Vascular Calcification and Fracture Risk in Dialysis Patients
por: Chen, Hung Yuan, et al.
Publicado: (2016)

Changes in serum albumin and other nutritional markers when using sucroferric oxyhydroxide as phosphate binder among hemodialysis patients: a historical cohort study
por: Kalantar-Zadeh, Kamyar, et al.
Publicado: (2019)

Associations of fetuin-A and osteoprotegerin with arterial stiffness and early atherosclerosis in chronic hemodialysis patients
por: Pateinakis, Panagiotis, et al.
Publicado: (2013)

Statins Improve Long Term Patency of Arteriovenous Fistula for Hemodialysis
por: Chang, Hao-Hsiang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_hp7q3fehdmmgofu66s8ev0h8dd